BIOMAT Database Logo BIOMAT Database Logo

Evaluation of dengue IgM detection tests using sera from patients with autoimmune diseases. 2002

Tomohiko Takasaki, and Masaru Nawa, and Ken Ichiro Yamada, and Makoto Harada, and Akira Takeda, and Ichiro Kurane
Department of Virology 1, Laboratory of Neurovirology, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, 162-8640, Tokyo, Japan. takasaki@nih.go.jp

Three commercial dengue IgM test kits and 'in-house' IgM-capture enzyme-linked immunosorbent assay (ELISA) were examined for false positive reactions, using 49 serum samples from patients with autoimmune diseases. All the samples were found to be negative by the 'in-house' IgM-capture ELISA. Five samples were determined to be positive by the immunochromatographic test and three of the five samples were also found positive by one commercial IgM-capture ELISA kit. These results suggest that a possibility of false positive reaction should be considered when serum samples from autoimmune disease patients are tested for dengue IgM by some commercial dengue IgM test kits.

UI MeSH Term Description Entries
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D011933 Reagent Kits, Diagnostic Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use. Diagnostic Reagent Kits,Diagnostic Reagents and Test Kits,Diagnostic Test Kits,In Vitro Diagnostic Device,In Vitro Diagnostic Devices,In Vitro Diagnostic Medical Device,In Vitro Diagnostic Medical Devices,Kits, Diagnostic Reagent,Diagnostic Reagent Kit,Diagnostic Test Kit,Kit, Diagnostic Reagent,Kit, Diagnostic Test,Kits, Diagnostic Test,Reagent Kit, Diagnostic,Test Kit, Diagnostic,Test Kits, Diagnostic
D003715 Dengue An acute febrile disease transmitted by the bite of AEDES mosquitoes infected with DENGUE VIRUS. It is self-limiting and characterized by fever, myalgia, headache, and rash. SEVERE DENGUE is a more virulent form of dengue. Dengue Fever,Break-Bone Fever,Breakbone Fever,Classical Dengue,Classical Dengue Fever,Break Bone Fever,Classical Dengue Fevers,Classical Dengues,Dengue Fever, Classical,Dengue, Classical,Fever, Break-Bone,Fever, Breakbone,Fever, Dengue
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity

Related Publications

Tomohiko Takasaki, and Masaru Nawa, and Ken Ichiro Yamada, and Makoto Harada, and Akira Takeda, and Ichiro Kurane
Evaluation of dengue NS1 antigen detection tests with acute sera from patients infected with dengue virus in Venezuela.
November 2009, Diagnostic microbiology and infectious disease,
Tomohiko Takasaki, and Masaru Nawa, and Ken Ichiro Yamada, and Makoto Harada, and Akira Takeda, and Ichiro Kurane
Detection of IgM antibodies from cerebrospinal fluid and sera of dengue fever patients.
December 1991, The Southeast Asian journal of tropical medicine and public health,
Tomohiko Takasaki, and Masaru Nawa, and Ken Ichiro Yamada, and Makoto Harada, and Akira Takeda, and Ichiro Kurane
Measles antibodies in sera from patients with autoimmune diseases.
January 1972, Lancet (London, England),
Tomohiko Takasaki, and Masaru Nawa, and Ken Ichiro Yamada, and Makoto Harada, and Akira Takeda, and Ichiro Kurane
[Studies of sera yielding biologically false reagin test results and sera from patients with autoimmune diseases and neoplasms. Treponemal tests].
January 1976, Przeglad dermatologiczny,
Tomohiko Takasaki, and Masaru Nawa, and Ken Ichiro Yamada, and Makoto Harada, and Akira Takeda, and Ichiro Kurane
Antibodies against Ku protein in sera from patients with autoimmune diseases.
June 1989, Clinical and experimental immunology,
Tomohiko Takasaki, and Masaru Nawa, and Ken Ichiro Yamada, and Makoto Harada, and Akira Takeda, and Ichiro Kurane
Antibodies against sulphatide in sera from patients with autoimmune rheumatic diseases.
March 1992, Clinical and experimental immunology,
Tomohiko Takasaki, and Masaru Nawa, and Ken Ichiro Yamada, and Makoto Harada, and Akira Takeda, and Ichiro Kurane
Evaluation of commercially available diagnostic tests for the detection of dengue virus NS1 antigen and anti-dengue virus IgM antibody.
October 2014, PLoS neglected tropical diseases,
Tomohiko Takasaki, and Masaru Nawa, and Ken Ichiro Yamada, and Makoto Harada, and Akira Takeda, and Ichiro Kurane
Agglutination of murine tumor cells by sera from patients with autoimmune diseases.
January 1979, International archives of allergy and applied immunology,
Tomohiko Takasaki, and Masaru Nawa, and Ken Ichiro Yamada, and Makoto Harada, and Akira Takeda, and Ichiro Kurane
Detection of IgM and IgG antibodies against SARS-CoV-2 in patients with autoimmune diseases.
July 2020, The Lancet. Rheumatology,
Tomohiko Takasaki, and Masaru Nawa, and Ken Ichiro Yamada, and Makoto Harada, and Akira Takeda, and Ichiro Kurane
Antibodies to heterogeneous nuclear ribonucleoproteins in sera from patients with rheumatic autoimmune diseases.
May 1984, Journal of clinical immunology,
Copied contents to your clipboard!